title: New drugs: Denosumab, dienogest/estradiol valerate, and polidocanol.
authors.affiliation: Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, USA.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
authors.forename: Takyiah
authors.initials: T
authors.lastname: Stevenson
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003270:Contraceptive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000069448:Denosumab; D004958:Estradiol / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D009277:Nandrolone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000517:prevention & control; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D053245:RANK Ligand / Q000009:adverse effects / Q000819:agonists / Q000627:therapeutic use*; D012597:Sclerosing Solutions / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003270:Contraceptive Agents; D053245:RANK Ligand; D012597:Sclerosing Solutions; C505688:TNFSF11 protein, human; D000077423:Polidocanol; D011092:Polyethylene Glycols; C023635:dienogest; D000069448:Denosumab; D004958:Estradiol; D009277:Nandrolone